Ceftriaxone & Tazobactam Injection 281.25 mg Supplier for Cape Town, South Africa
High-Quality Injectable Antibiotic from India
Ernest Oncology offers Ceftriaxone & Tazobactam Injection 281.25 mg, a sterile injectable antibiotic formulated with Ceftriaxone 250 mg and Tazobactam 31.25 mg. Manufactured in India using advanced pharmaceutical technology, this medicine is intended for intramuscular (IM) and intravenous (IV) administration by qualified healthcare professionals.
Every batch is produced under stringent quality controls to ensure safety, purity, and consistent pharmaceutical performance.
Product Overview
| Product Details | Information |
|---|---|
| Product Name | Ceftriaxone & Tazobactam Injection |
| Total Strength | 281.25 mg |
| Composition | Ceftriaxone 250 mg + Tazobactam 31.25 mg |
| Dosage Form | Sterile Powder for Injection |
| Route of Administration | IM / IV |
| Therapeutic Category | Broad-Spectrum Antibiotic |
| Packaging | Sterile Export Packaging |
| Country of Origin | India |
Key Features
- Ceftriaxone and Tazobactam combination
- Broad-spectrum antibacterial formulation
- Sterile injectable preparation
- WHO-GMP manufactured
- High pharmaceutical purity
- Reliable formulation stability
- Export-quality packaging
- Batch-tested quality
- Clinical-grade manufacturing
- International quality compliance
Product Description
Ceftriaxone & Tazobactam Injection 281.25 mg combines the antibacterial activity of Ceftriaxone, a third-generation cephalosporin antibiotic, with Tazobactam, a beta-lactamase inhibitor. This combination is prescribed under medical supervision for the treatment of susceptible bacterial infections where enhanced antibacterial activity is required.
The medicine is intended for administration by qualified healthcare professionals according to approved clinical guidelines.
Mechanism of Action
The two active ingredients work together to provide broader antibacterial effectiveness.
- Ceftriaxone inhibits bacterial cell wall synthesis, resulting in bacterial cell death.
- Tazobactam blocks beta-lactamase enzymes produced by certain bacteria, helping maintain the antibacterial activity of Ceftriaxone.
Together they improve activity against susceptible bacterial organisms.
Recommended Dosage
Dosage should always be prescribed by a qualified healthcare professional.
The recommended dose depends upon:
- Type of infection
- Severity of illness
- Patient age
- Body weight
- Kidney function
- Overall clinical assessment
Do not self-administer this medicine.
Side Effects
Some individuals may experience temporary side effects.
Possible reactions include:
- Pain at the injection site
- Nausea
- Vomiting
- Diarrhea
- Headache
- Skin rash
- Fever
- Dizziness
- Allergic reactions
- Temporary elevation of liver enzymes
Consult a healthcare professional if symptoms persist or worsen.
Safety Information
- Prescription-only medicine.
- Use only under medical supervision.
- Inform your doctor about any allergies before treatment.
- Complete the prescribed treatment course.
- Follow healthcare provider instructions carefully.
- Do not use expired medicine.
- Keep out of reach of children.
Storage Information
- Store below 25°C
- Protect from moisture
- Keep away from direct sunlight
- Store in original packaging
- Do not freeze
- Use before expiry date
Cape Town Pharmaceutical Market
Cape Town is one of South Africa's leading healthcare hubs, supported by modern hospitals, specialist medical centres, and expanding healthcare infrastructure. The growing need for quality anti-infective therapies has increased demand for internationally manufactured injectable antibiotics that comply with recognized pharmaceutical standards.
Indian pharmaceutical manufacturers continue to support healthcare systems worldwide through advanced manufacturing practices, reliable product quality, and internationally accepted production standards.
Why Choose Indian Pharmaceutical Exports
India has become one of the world's most trusted pharmaceutical manufacturing destinations.
Advantages of Indian Pharmaceutical Products
- WHO-GMP certified manufacturing facilities
- International quality standards
- Modern pharmaceutical production technology
- Consistent product quality
- Strict quality assurance procedures
- Reliable manufacturing capabilities
- Export-quality packaging
- Strong global healthcare presence
- Continuous product monitoring
- Worldwide pharmaceutical recognition
Quality Assurance
Every batch supplied by Ernest Oncology is manufactured using internationally accepted pharmaceutical quality systems.
Our Quality Commitment
- WHO-GMP certified manufacturing facilities
- Sterile manufacturing process
- Batch quality inspection
- Product traceability
- Export-grade packaging
- Controlled storage conditions
- Documentation verification
- Continuous quality monitoring
Documentation
Available export documentation includes:
- Commercial Invoice
- Packing List
- Certificate of Analysis (COA)
- Certificate of Origin (COO)
- Product Specification Sheet
- Certificate of Pharmaceutical Product (CPP)* (where available)
- Batch Manufacturing Record*
- Airway Bill / Bill of Lading
Partner with Ernest Oncology
Ernest Oncology is committed to delivering trusted pharmaceutical products manufactured in India for healthcare professionals and medical institutions worldwide. Our focus remains on quality manufacturing, innovation, patient safety, and international pharmaceutical standards.
Frequently Asked Questions (FAQs)
1. What does Ceftriaxone & Tazobactam Injection 281.25 mg contain?
It contains Ceftriaxone 250 mg and Tazobactam 31.25 mg in a sterile injectable formulation.
2. How is the medicine administered?
It is administered by intramuscular (IM) or intravenous (IV) injection under medical supervision.
3. What is the function of Tazobactam?
Tazobactam inhibits beta-lactamase enzymes, helping protect Ceftriaxone and improve its antibacterial activity.
4. How should the medicine be stored?
Store below 25°C, protected from moisture and direct sunlight.
5. Is this medicine available without a prescription?
No. It is a prescription-only medicine and should only be used under the supervision of a qualified healthcare professional.
📞 Contact Ernest Oncology — Advancing Global Healthcare from India
A Specialized Healthcare Brand of Ernest Pharmaceutical Pvt. Ltd.
🌐 Official Websites
- www.oncologymedicinesupplier.com
- www.ernestpharmaceuticals.com
- www.ernestvision.com
- www.ernestimpex.com
exports@ernestpharmaceuticals.com
🌍 Our Services
- Quality Pharmaceutical Products
- International Healthcare Solutions
- Sterile Injectable Medicines
- Pharmaceutical Innovation from India
+91 93599 02383
Medical Disclaimer
Ceftriaxone & Tazobactam Injection 281.25 mg is a prescription-only medicine. The information provided on this page is intended for educational purposes only and should not be considered a substitute for professional medical advice. This medicine should always be administered by qualified healthcare professionals following approved prescribing guidelines.
Description
Ernest Oncology supplies Ceftriaxone & Tazobactam Injection 281.25 mg (Ceftriaxone 250 mg & Tazobactam 31.25 mg) from India to Cape Town, South Africa. Premium sterile antibiotic injection manufactured under WHO-GMP standards with international pharmaceutical quality.
- Ceftriaxone & Tazobactam Injection 562.5 mg
- Ceftriaxone & Tazobactam Injection 1125 mg
- Ceftriaxone & Sulbactam Injection 750 mg
- Ceftriaxone & Sulbactam for Injection 1.5 g
- Cefpirome Sulphate Injection 1 g (1000 mg)
Written By
Chaitali H.
B. Pharma